Reduction of morning stiffness and improvement in physical function in fibromyalgia syndrome patients treated sublingually with low doses of human interferon-α

Medicine and Dentistry

• Interferon 100%
• Fibromyalgia 60%
• Patient 60%
• Morning Stiffness 40%
• Low Drug Dose 20%
• Follow up 20%
• Combination Therapy 20%
• Adverse Event 20%
• Screening 20%
• Anodyne 20%
• Evaluation Study 20%
• Hypnotic Sedative Agent 20%
• Human Interferon 20%
• Volunteer 20%
• Medication 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Interferon 100%
• Placebo 80%
• Fibromyalgia 60%
• Syndrome 60%
• Morning Stiffness 40%
• Adverse Event 20%
• Analgesic Agent 20%
• Human Interferon 20%
• Hypnotic Sedative Agent 20%

Neuroscience

• Interferon 100%
• Fibromyalgia 60%
• Placebo 40%
• Human Interferon 20%